Susquehanna International Group, LLP Bio Xcel Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 15, 2024	BUY	$1.14 - $2.97 $8,322 - $21,681	7,300 Added 9.99%	80,400 $102,000
Q1 2024 May 07, 2024	BUY	$1.95 - $4.04 $96,720 - $200,384	49,600 Added 211.06%	73,100 $206,000
Q4 2023 Feb 14, 2024	SELL	$2.32 - $5.51 $719,664 - $1.71 Million	-310,200 Reduced 92.96%	23,500 $69,000
Q3 2023 Nov 14, 2023	BUY	$2.49 - $11.85 $721,602 - $3.43 Million	289,800 Added 660.14%	333,700 $844,000
Q2 2023 Aug 11, 2023	SELL	$6.39 - $28.58 $391,068 - $1.75 Million	-61,200 Reduced 58.23%	43,900 $292,000
Q1 2023 May 16, 2023	BUY	$17.7 - $33.24 $1.22 Million - $2.29 Million	69,000 Added 191.14%	105,100 $1.96 Million
Q4 2022 Feb 14, 2023	SELL	$10.25 - $22.43 $65,600 - $143,552	-6,400 Reduced 15.06%	36,100 $775,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $193,587 - $309,497	17,300 Added 68.65%	42,500 $502,000
Q2 2022 Aug 15, 2022	SELL	$9.03 - $21.55 $430,730 - $1.03 Million	-47,700 Reduced 65.43%	25,200 $333,000
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $507,000 - $771,654	33,800 Added 86.45%	72,900 $1.52 Million
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $1.84 Million - $3.21 Million	-91,400 Reduced 70.04%	39,100 $795,000
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $674,672 - $906,449	28,300 Added 27.69%	130,500 $3.96 Million
Q2 2021 Aug 11, 2021	BUY	$29.06 - $38.83 $1.87 Million - $2.5 Million	64,500 Added 171.09%	102,200 $2.97 Million
Q1 2021 May 17, 2021	SELL	$39.04 - $64.6 $4.75 Million - $7.86 Million	-121,600 Reduced 76.33%	37,700 $1.63 Million
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $2.48 Million - $3.3 Million	58,400 Added 57.88%	159,300 $7.36 Million
Q3 2020 Nov 16, 2020	SELL	$37.44 - $64.63 $3.74 Million - $6.46 Million	-99,900 Reduced 49.75%	100,900 $4.38 Million
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $2.61 Million - $8.69 Million	148,000 Added 280.3%	200,800 $10.6 Million
Q1 2020 May 15, 2020	BUY	$12.26 - $41.14 $647,328 - $2.17 Million	52,800 New	52,800 $1.18 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

6.99M

Call Options Held

101K

Put Options Held

198K

Vanguard Group Inc Valley Forge, PA

1.2M
Shares

$744,853
0.0% of portfolio
Black Rock Inc. New York, NY

441K
Shares

$273,224
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

298K
Shares

$184,786
0.0% of portfolio
Wells Fargo & Company San Francisco, CA

185K
Shares

$114,735
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

130K
Shares

$80,518
0.0% of portfolio

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $17.4M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account